List of works - Suerie Moon

A New Golden Age? Proposal for an Innovative Global Health Funding Mechanism for Middle-Income Countries

scientific article published on 21 September 2017

A global pandemic treaty should aim for deep prevention

scientific article published in May 2021

A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries ⬇️

scientific article published on September 14, 2010

A pandemic treaty for a fragmented global polity

scientific article published in June 2021

A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries

scientific article published on 12 October 2011

Advancing Innovation and Access to Medicines

scientific article published on 30 May 2022

Averting Future Vaccine Injustice

scientific article published on 15 July 2021

Building a tuberculosis-free world: The Lancet Commission on tuberculosis

scientific article published on 20 March 2019

Defining the concept of fair pricing for medicines

scientific article published on 13 January 2020

Development assistance for health: critiques, proposals and prospects for change

scientific article published in April 2017

Development assistance for health: what criteria do multi- and bilateral funders use?

scientific article published on April 2017

Distributing development assistance for health: simulating the implications of 11 criteria

scientific article published on April 2017

Driving a decade of change: HIV/AIDS, patents and access to medicines for all.

scientific article

Embedding global access in development of future pandemic vaccines

scientific article published in 2021

Embedding neoliberalism

PhD thesis by Suerie Moon

Facing forward after Ebola: questions for the next director general of the World Health Organization

scientific article published on 18 May 2016

Focusing on quality patient care in the new global subsidy for malaria medicines

scientific article

From sovereignty to solidarity: a renewed concept of global health for an era of complex interdependence

scientific article published on January 2014

Getting pandemic prevention right

scientific article

Global Health

scientific article published on 30 November 2021

Global epidemics: how well can we cope?

scientific article published on 09 August 2018

Global health law and governance: concepts, tools, actors and power

scientific article published on 30 November 2018

Global public goods for health: weaknesses and opportunities in the global health system

scientific article published on April 2017

Global rules for global health: why we need an independent, impartial WHO.

scientific article published on 18 June 2014

Governance challenges in global health

scientific article published on March 2013

Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability

scientific article published on 29 January 2022

Informal Norms in Global Governance

scientific article published on 23 May 2016

Innovation and access to medicines for neglected populations: could a treaty address a broken pharmaceutical R&D system?

scientific article

Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets

scientific article

Lancet Commission on synergies between universal health coverage, health security, and health promotion ⬇️

Making technological innovation work for sustainable development.

scientific article

New business models for research and development with affordability requirements are needed to achieve fair pricing of medicines

scientific article published on 13 January 2020

Non-commercial pharmaceutical R&D: what do neglected diseases suggest about costs and efficiency?

scientific article published in 2021

Out-of-pocket costs of AIDS care in China: are free antiretroviral drugs enough?

scientific article published on September 2008

Pharmaceutical policy and innovation for rare diseases: A narrative review

scientific article published in 2023

Post-Ebola reforms: ample analysis, inadequate action

scientific article (publication date: 23 January 2017)

Post-covid reforms: can we avoid fighting the last war?

scientific article published on 19 May 2021

Power in global governance: an expanded typology from global health

scientific article published on 28 November 2019

Powerful Ideas for Global Access to Medicines

scientific article published on 18 January 2017

Pricing of pharmaceuticals is becoming a major challenge for health systems

scientific article published on 13 January 2020

Projected savings through public health voluntary licences of HIV drugs negotiated by the Medicines Patent Pool (MPP).

scientific article

Reboot biomedical R&D in the global public interest

scientific article published on 9 February 2022

Reimagining Global Health Governance in the Age of COVID-19

scientific article published on 01 November 2020

Removing the blindfold on medicines pricing

scientific article published on 26 February 2018

Respecting the right to access to medicines: Implications of the UN Guiding Principles on Business and Human Rights for the pharmaceutical industry

scientific article published on 14 June 2013

Rising pharmaceutical innovation in the Global South: a landscape study

scientific article published on 27 November 2023

Should we question our current model for encouraging innovation in the pharmaceutical sector?

scientific article published in December 2022

The Global Politics of Access to Medicines

scientific article published on 4 September 2019

The World Trade Organization

academic chapter published on 19 April 2018

The challenge of middle-income countries to development assistance for health: recipients, funders, both or neither?

scientific article published on April 2017

The global health system: actors, norms, and expectations in transition

scientific article

The global health system: lessons for a stronger institutional framework.

scientific article

The global health system: linking knowledge with action--learning from malaria

scientific article (publication date: 19 January 2010)

The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children

scientific article

The political origins of health inequity: Prospects for change

scientific article published on 11 February 2014

Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola

scientific article

Towards a coherent global framework for health financing: recommendations and recent developments

scientific article published in April 2017

Travel restrictions and infectious disease outbreaks

scientific article published on 16 April 2020

Universal Medicine Access through Lump-Sum Remuneration - Australia's Approach to Hepatitis C

scientific article published on 01 February 2019

Viewing the global health system as a complex adaptive system - implications for research and practice

scientific article published in 2022

WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerations

scientific article published on 25 March 2022

WHO's role in the global health system: what can be learned from global R&D debates?

scientific article published on 03 January 2014

Which roads lead to access? A global landscape of six COVID-19 vaccine innovation models

scientific article published on 26 March 2024

Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola

scientific article published in November 2015

Will markets be master or servant to health at the World Bank?

scientific article published on 17 October 2017

List of works by Suerie Moon

A New Golden Age? Proposal for an Innovative Global Health Funding Mechanism for Middle-Income Countries

A global pandemic treaty should aim for deep prevention

A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries ⬇️

A pandemic treaty for a fragmented global polity

A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries

Advancing Innovation and Access to Medicines

Averting Future Vaccine Injustice

Building a tuberculosis-free world: The Lancet Commission on tuberculosis

Defining the concept of fair pricing for medicines

Development assistance for health: critiques, proposals and prospects for change

Development assistance for health: what criteria do multi- and bilateral funders use?

Distributing development assistance for health: simulating the implications of 11 criteria

Driving a decade of change: HIV/AIDS, patents and access to medicines for all.

Embedding global access in development of future pandemic vaccines

Embedding neoliberalism

Facing forward after Ebola: questions for the next director general of the World Health Organization

Focusing on quality patient care in the new global subsidy for malaria medicines

From sovereignty to solidarity: a renewed concept of global health for an era of complex interdependence

Getting pandemic prevention right

Global Health

Global epidemics: how well can we cope?

Global health law and governance: concepts, tools, actors and power

Global public goods for health: weaknesses and opportunities in the global health system

Global rules for global health: why we need an independent, impartial WHO.

Governance challenges in global health

Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability

Informal Norms in Global Governance

Innovation and access to medicines for neglected populations: could a treaty address a broken pharmaceutical R&D system?

Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets

Lancet Commission on synergies between universal health coverage, health security, and health promotion ⬇️

Making technological innovation work for sustainable development.

New business models for research and development with affordability requirements are needed to achieve fair pricing of medicines

Non-commercial pharmaceutical R&D: what do neglected diseases suggest about costs and efficiency?

Out-of-pocket costs of AIDS care in China: are free antiretroviral drugs enough?

Pharmaceutical policy and innovation for rare diseases: A narrative review

Post-Ebola reforms: ample analysis, inadequate action

Post-covid reforms: can we avoid fighting the last war?

Power in global governance: an expanded typology from global health

Powerful Ideas for Global Access to Medicines

Pricing of pharmaceuticals is becoming a major challenge for health systems

Projected savings through public health voluntary licences of HIV drugs negotiated by the Medicines Patent Pool (MPP).

Reboot biomedical R&D in the global public interest

Reimagining Global Health Governance in the Age of COVID-19

Removing the blindfold on medicines pricing

Respecting the right to access to medicines: Implications of the UN Guiding Principles on Business and Human Rights for the pharmaceutical industry

Rising pharmaceutical innovation in the Global South: a landscape study

Should we question our current model for encouraging innovation in the pharmaceutical sector?

The Global Politics of Access to Medicines

The World Trade Organization

The challenge of middle-income countries to development assistance for health: recipients, funders, both or neither?

The global health system: actors, norms, and expectations in transition

The global health system: lessons for a stronger institutional framework.

The global health system: linking knowledge with action--learning from malaria

The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children

The political origins of health inequity: Prospects for change

Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola

Towards a coherent global framework for health financing: recommendations and recent developments

Travel restrictions and infectious disease outbreaks

Universal Medicine Access through Lump-Sum Remuneration - Australia's Approach to Hepatitis C

Viewing the global health system as a complex adaptive system - implications for research and practice

WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerations

WHO's role in the global health system: what can be learned from global R&D debates?

Which roads lead to access? A global landscape of six COVID-19 vaccine innovation models

Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola

Will markets be master or servant to health at the World Bank?